Clinical Trials Directory

Trials / Unknown

UnknownNCT02137616

Antipsychotic to Treat Psychosis Syndrome

Effectiveness of Antipsychotic Drugs to Treat Psychosis Syndrome: an Open Label, Controlled Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
300 (estimated)
Sponsor
Central South University · Academic / Other
Sex
All
Age
16 Years – 30 Years
Healthy volunteers
Not accepted

Summary

This study assess the safety and effects of atypical antipsychotics in subjects with psychosis syndrome and psychosis risk syndrome.

Detailed description

The investigators investigated whether administration of atypical antipsychotics could alleviate prodromal symptoms and be well tolerated by subjects with psychosis syndrome and psychosis risk syndrome.

Conditions

Interventions

TypeNameDescription
DRUGrisperidoneRisperdal tablets
DRUGolanzapineolanzapine tablets
DRUGQuetiapinequetiapine tablets
DRUGAripiprazoleAripiprazole tablets

Timeline

Start date
2012-06-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2014-05-14
Last updated
2014-05-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02137616. Inclusion in this directory is not an endorsement.